- Home
- SWZ vs CRVO Comparison
SWZ vs CRVO Comparison
Compare SWZ & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWZ
- CRVO
- Stock Information
- Founded
- SWZ 1986
- CRVO 2001
- Country
- SWZ United States
- CRVO United States
- Employees
- SWZ N/A
- CRVO N/A
- Industry
- SWZ Finance Companies
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- SWZ Finance
- CRVO Health Care
- Exchange
- SWZ Nasdaq
- CRVO Nasdaq
- Market Cap
- SWZ 82.2M
- CRVO 69.3M
- IPO Year
- SWZ N/A
- CRVO N/A
- Fundamental
- Price
- SWZ $6.32
- CRVO $7.22
- Analyst Decision
- SWZ
- CRVO Strong Buy
- Analyst Count
- SWZ 0
- CRVO 8
- Target Price
- SWZ N/A
- CRVO $25.57
- AVG Volume (30 Days)
- SWZ 14.2K
- CRVO 234.7K
- Earning Date
- SWZ 01-01-0001
- CRVO 05-12-2025
- Dividend Yield
- SWZ 6.59%
- CRVO N/A
- EPS Growth
- SWZ N/A
- CRVO N/A
- EPS
- SWZ N/A
- CRVO N/A
- Revenue
- SWZ N/A
- CRVO $9,308,215.00
- Revenue This Year
- SWZ N/A
- CRVO N/A
- Revenue Next Year
- SWZ N/A
- CRVO N/A
- P/E Ratio
- SWZ N/A
- CRVO N/A
- Revenue Growth
- SWZ N/A
- CRVO 15.14
- 52 Week Low
- SWZ $7.12
- CRVO $1.80
- 52 Week High
- SWZ $8.57
- CRVO $22.57
- Technical
- Relative Strength Index (RSI)
- SWZ 34.64
- CRVO 35.85
- Support Level
- SWZ $6.24
- CRVO $7.51
- Resistance Level
- SWZ $6.36
- CRVO $8.59
- Average True Range (ATR)
- SWZ 0.06
- CRVO 0.50
- MACD
- SWZ 0.08
- CRVO -0.17
- Stochastic Oscillator
- SWZ 64.29
- CRVO 8.40
About SWZ Swiss Helvetia Fund Inc. (The)
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, Semiconductors, Information Technology, and retail.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.